azathioprine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 7 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Detection of the chronic myelogenous leukemia (CML)-related marker, the bcr/abl m-RNA transcript, in blood or bone marrow of patients with CML in hematologic remission after allogeneic bone marrow transplantation (allo-BMT) may be associated with the presence of minimal residual disease but does not uniformly predict hematologic relapse." | 1.29 | Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation. ( Agaliotis, DP; Elfenbein, GJ; Moscinski, LC; Papenhausen, PR, 1995) |
| "A patient is reported who developed chronic myelogenous leukemia (CML) six years after renal transplantation, which was followed by immunosuppressive with azathioprine, and the published data on such an association are reviewed." | 1.29 | [Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography]. ( Cervantes, F; Esteve, J; Marín, P; Montserrat, E; Rozman, C; Sanz, L; Vilardell, J, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zaimi, Y | 1 |
| Bouksir, C | 1 |
| Ayadi, S | 1 |
| Ayari, M | 1 |
| Ksontini, FL | 1 |
| Pelloso, LA | 1 |
| Campos, MG | 1 |
| Nascimento, M | 1 |
| Silva, MR | 1 |
| Pestana, JO | 1 |
| Chauffaille, Mde L | 1 |
| Habib, S | 1 |
| Nalesnik, MA | 1 |
| Ahmad, J | 1 |
| BuchBarker, D | 1 |
| Shakil, AO | 1 |
| Segawa, F | 1 |
| Shimizu, Y | 1 |
| Saito, E | 1 |
| Kinoshita, M | 1 |
| Agaliotis, DP | 1 |
| Papenhausen, PR | 1 |
| Moscinski, LC | 1 |
| Elfenbein, GJ | 1 |
| Sanz, L | 1 |
| Cervantes, F | 1 |
| Esteve, J | 1 |
| Vilardell, J | 1 |
| Marín, P | 1 |
| Rozman, C | 1 |
| Montserrat, E | 1 |
| Mignozzi, M | 1 |
| Picca, S | 1 |
1 review available for azathioprine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Imputability of Azathioprine in the Occurrence of Chronic Myeloid Leukemia in Crohn's Disease: An Exceptional Case Report.
Topics: Azathioprine; Chronic Disease; Crohn Disease; Female; Humans; Immunosuppressive Agents; Leukemia, My | 2023 |
6 other studies available for azathioprine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Chronic myeloid leukemia following kidney transplantation.
Topics: Adult; Azathioprine; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantatio | 2005 |
Alloimmune hepatitis following peripheral stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Busulfan; Cyclophosphamide; Female; Graft vs Host Dis | 2007 |
Behçet's disease induced by interferon therapy for chronic myelogenous leukemia.
Topics: Azathioprine; Behcet Syndrome; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR | 1995 |
Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.
Topics: Adult; Azathioprine; Blast Crisis; Bone Marrow Transplantation; Female; Graft vs Host Disease; Human | 1995 |
[Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography].
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Hydroxyurea; Immunosuppressive Agents; Incidence; | 1996 |
Chronic myelogenous leukemia following kidney transplantation in a pediatric patient.
Topics: Adolescent; Antineoplastic Agents; Azathioprine; Human Growth Hormone; Humans; Hydroxyurea; Immunosu | 2001 |